Loading...
Loading...
India's ezetimibe imports from UNITED STATES total $169.2K across 51 shipments from 15 foreign suppliers. NEW LIFE MEDICALS (USA) INC., leads with $27.1K in import value; the top 5 suppliers together control 61.9% of this origin. Leading Indian buyers include MICRO LABS LIMITED. This corridor reflects India's pharmaceutical import demand for ezetimibe โ a diversified sourcing base with multiple active suppliers from UNITED STATES.

NEW LIFE MEDICALS (USA) INC., is the leading Ezetimibe supplier from UNITED STATES to India, with import value of $27.1K across 1 shipments. The top 5 suppliers โ NEW LIFE MEDICALS (USA) INC.,, ESPEE BIOPHARMA & FINECHEM LLC, REGIONAL PHARMACY, Pharmaceutical Buyers, Inc, NEWLIFE MEDICALS USA INC โ collectively account for 61.9% of total import value from this origin.
Ranked by import value (USD) ยท Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | NEW LIFE MEDICALS (USA) INC., | $27.1K | 1 | 16.0% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $23.3K | 12 | 13.8% |
| 3 | REGIONAL PHARMACY | $21.5K | 3 | 12.7% |
| 4 | Pharmaceutical Buyers, Inc | $17.7K | 9 | 10.4% |
| 5 | NEWLIFE MEDICALS USA INC | $15.1K | 1 | 8.9% |
| 6 | AMSTERDAM PHARMA(APTEKA RX INC.) | $10.1K | 4 | 6.0% |
| 7 | NEW LIFE MEDICALS (USA) INC | $10.0K | 1 | 5.9% |
| 8 | AGRACE PHARMA. | $8.3K | 1 | 4.9% |
| 9 | NEW LIFE MEDICALS LLC., | $7.2K | 1 | 4.2% |
| 10 | NEW LIFE MEDICALS (USA), INC. | $6.6K | 1 | 3.9% |
| 11 | AMSTERDAM PHARMA APTEKA RX INC | $5.0K | 3 | 3.0% |
| 12 | GOOD HEALTH PHARMA SUPPLIES | $4.2K | 2 | 2.5% |
| 13 | ESPEE BIOPHARMA FINECHEM LLC | $3.3K | 1 | 2.0% |
| 14 | AGRACE PHARMA | $3.2K | 1 | 1.9% |
| 15 | SSS PHARMACY INC | $2.5K | 1 | 1.5% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MICRO LABS LIMITED | $43.2K | 4 | 25.5% |
| 2 | INTAS PHARMACEUTICALS LIMITED | $21.7K | 3 | 12.8% |
| 3 | IPCA LABORATORIES LIMITED | $19.3K | 5 | 11.4% |
| 4 | MYLAN LABORATORIES LIMITED | $17.2K | 8 | 10.2% |
| 5 | DR.REDDY'S LABORATORIES LTD | $16.7K | 4 | 9.8% |
| 6 | HETERO LABS LIMITED | $16.2K | 4 | 9.6% |
| 7 | AUROBINDO PHARMA LTD | $12.3K | 6 | 7.3% |
| 8 | AJANTA PHARMA LIMITED | $9.6K | 2 | 5.7% |
| 9 | OPTIMUS PHARMA PVT LTD | $3.9K | 1 | 2.3% |
| 10 | TORRENT PHARMACEUTICALS LTD | $3.0K | 1 | 1.8% |
| 11 | DR.REDDY'S LABORATORIES LIMITED | $1.8K | 1 | 1.0% |
| 12 | DR REDDYS LABORATORIES LIMITED | $1.1K | 2 | 0.6% |
| 13 | WATSON PHARMA PRIVATE LIMITED | $939 | 3 | 0.6% |
| 14 | ACTAVIS PHARMA DEVELOPMENT CENTRE PRIVATE LIMITED | $799 | 3 | 0.5% |
| 15 | AMI LIFESCIENCES PVT LTD | $768 | 1 | 0.5% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Ezetimibe suppliers from UNITED STATES to India include NEW LIFE MEDICALS (USA) INC.,, ESPEE BIOPHARMA & FINECHEM LLC, REGIONAL PHARMACY. The leading supplier is NEW LIFE MEDICALS (USA) INC., with import value of $27.1K USD across 1 shipments. India imported Ezetimibe worth $169.2K USD from UNITED STATES in total across 51 shipments.
India imported Ezetimibe worth $169.2K USD from UNITED STATES across 51 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Ezetimibe sourced from UNITED STATES include MICRO LABS LIMITED, INTAS PHARMACEUTICALS LIMITED, IPCA LABORATORIES LIMITED. The largest buyer is MICRO LABS LIMITED with $43.2K in imports across 4 shipments.
The total value of Ezetimibe imports from UNITED STATES to India is $169.2K USD, across 51 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records โ the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
51 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists